[Epidemiology and pathophysiology of pain--new targets for pain therapy]

Hans-Georg Schaible1

  • 1Institut für Physiologie 1/Neurophysiologie, Universitätskinikum Jena, Teichgraben 8, 07743 Jena. Hans-Georg.Schaible@mti.uni-jena.de

Medizinische Monatsschrift Fur Pharmazeuten
|May 28, 2009
PubMed

Insights

Despite available pain medications, chronic pain persists, particularly in musculoskeletal tissues. New therapeutic strategies targeting molecular pain mechanisms and central nervous system processing are crucial for improved pain management.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pharmacology

Context:

  • Chronic pain affects numerous individuals, often originating in the musculoskeletal system.
  • Existing pain medications are insufficient for many suffering from persistent pain.
  • Novel therapeutic approaches are needed to address the complex nature of chronic pain.

Purpose:

  • To explore new therapeutic targets for chronic pain management.
  • To investigate molecular mechanisms underlying nociception and pain processing.
  • To identify strategies for improving pain treatment by understanding pathophysiological pain generation.

Summary:

  • Research into molecular mechanisms of nociception and central nervous system pain processing is vital.
  • Therapeutic strategies may involve modulating peripheral transduction, antagonizing algesic mediators, and attenuating central synaptic processes.
  • Potential new targets include TRPV1 receptors, cytokine and neuropeptide receptors, glutamate receptors, and ion channels.

Impact:

  • Advances in understanding pain mechanisms can lead to the development of more effective pain therapies.
  • Identifying novel drug targets offers hope for improved management of chronic pain conditions.
  • Exploring neuronal mechanisms of placebo effects may reveal new therapeutic pathways.

Related Concept Videos

Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
Pain01:20

Pain

Pain serves as a critical warning signal that alerts the body to potential or actual harm. When mechanical pressure on the skin is intense, such as from a sharp pinch, the sensation transitions from touch to pain. Similarly, extreme temperatures, like a hot pot handle, convert the sensation of heat into pain. Pain can also result from overstimulation of other senses, such as blinding light, loud noise, or the intense heat from habañero peppers. This ability to sense pain is essential for...
Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...